Rundu Pharma: Passed the on-site inspection by the European Medicines Agency

Zhitong
2025.10.09 08:13

Rundu Pharma announced that from May 14, 2025, to May 16, 2025, the company underwent an on-site GMP inspection of the active pharmaceutical ingredient CEP by the European Directorate for the Quality of Medicines & HealthCare (EDQM). Recently, the company received the "Inspection Certificate" issued by EDQM, and the inspection was successfully passed

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer